Benefits of new COVID-19 booster targeting variants outweigh any potential risks, experts say
The benefits of a new COVID-19 booster that targets omicron variants far outweigh the possible risks, experts say.
Aug 25, 2022
0
25
The benefits of a new COVID-19 booster that targets omicron variants far outweigh the possible risks, experts say.
Aug 25, 2022
0
25
A University of Minnesota assistant professor is part of a team that has developed a new way to effectively deliver vaccines through mucosal tissues in the nose that could lead to better protection against pathogens like ...
Aug 10, 2022
0
66
Neuroscientists have gained new insight into how our brain evolved into a language-ready brain. Compared to chimpanzee brains, the pattern of connections of language areas in our brain has expanded more than previously thought. ...
Jul 5, 2022
0
250
In a new brain-wide circuit tracing study, scientists at MIT's Picower Institute for Learning and Memory focused selective attention on a circuit that governs, fittingly enough, selective attention. The comprehensive maps ...
Apr 21, 2022
0
89
Keeping our eyes focused on what we reach for, whether it be an item at the grocery store or a ground ball on the baseball field, may appear seamless, but, in fact, is due to a complex neurological process involving intricate ...
Apr 20, 2022
0
51
According to estimates by the World Health Organization (WHO) more than 5% of the world's population is affected by hearing loss and deafness, which is mostly caused by loss of hair cells in the ear. For future treatment, ...
Mar 28, 2022
0
1
Researchers at La Jolla Institute for Immunology (LJI) are designing better therapies for treating Ebola virus and its deadly relatives.
Mar 17, 2022
0
65
Nearly four decades after its discovery, HIV has killed 36.3 million people, with no vaccine in sight. However, a new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, ...
Feb 4, 2022
0
180
An experimental HIV vaccine based on mRNA—the same platform technology used in two highly effective COVID-19 vaccines—shows promise in mice and non-human primates, according to scientists at the National Institute of ...
Dec 9, 2021
0
129
A monoclonal antibody cocktail against the COVID-19 virus discovered at Vanderbilt University Medical Center and developed by AstraZeneca reduced the risk of symptoms in a study of immunocompromised and chronically ill adults ...
Aug 20, 2021
0
150